Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |